伊朗乳腺癌遗传查测试的成本效益分析
Zahra Meshkani1,2, Najmeh Moradi3, Ali Aboutorabi4
1Department of Health Economics, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran. z_moshkani@yahoo.com.
BMC cancer
|March 1, 2024
概括
在伊朗,基于家族史 (FH) 的乳腺癌基因查比基于人口的查更具成本效益. 这种方法为早期检测和干预提供了更好的效益成本比率 (BCR).
科学领域:
- 卫生经济学 卫生经济学
- 在瘤学瘤学.
- 基因查 基因查 基因查
背景情况:
- 伊朗的乳腺癌查面临挑战,不到10%的病例与基因突变有关.
- 评估具有成本效益的查策略对于医疗保健的资源配置至关重要.
研究的目的:
- 在伊朗对基于人口和家族史 (FH) 的乳腺癌基因查进行经济评估.
- 为了确定不同遗传查策略的效益成本比率 (BCR).
主要方法:
- 使用支付意愿 (WTP) 方法和条件估值方法 (CVM) 的经济评估.
- 开发了一个决策模型,从医疗保健的角度模拟成本,包括直接的医疗和非医疗费用.
- 进行了单向灵敏度分析,以评估研究结果的可靠性.
主要成果:
- 每个基因查测试的成本为以人口为基础的策略为167美元,以FH为基础的策略为8美元.
- 在以人口为基础的查中,BCR为0.12,在以FH为基础的查中为3.37.
- 遗传查测试的货币价值有所不同,女性家族病史或基因突变的价值更高.
结论:
- 在伊朗,建议采用基于家族史 (FH) 的基因查策略,而不是基于人口的方法.
- 未来的研究应该评估乳腺癌的级联基因查测试策略.
更多相关视频
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
9.0K
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
407
相关概念视频
Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
